COBAS AMPLICOR CHLAMYDIA TACHOMATIS TEST 20757497122

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2011-09-15 for COBAS AMPLICOR CHLAMYDIA TACHOMATIS TEST 20757497122 manufactured by Roche Molecular Systems.

Event Text Entries

[9348924] (b)(4): method: analysis of labeling and (review of trend data and analysis of raw data from the customer site). Result: device performed according to specifications. Conclusion : no failure detected and product performed within specification. No product or batch non-conformance was identified. Analysis of the raw data shows, that the patient was symptomatic, and the negative ct result is considered to be a false (b)(6) result. Upon investigation there was no trend found in the field. Qc release data for the kit batches met specifications. Kit batch n18071 generated acceptable results during stability testing. As per the method manual, the sensitivity of the test is not 100% when on-label sample types are tested. As no statistics (positive predicative values, negative predictive values, false positive rates, false negative rates, and the number of samples tested in a given year) were provided through the current case, no further analysis could be performed to determine if the false negative result falls within the claims of the test. As stated in the cobas amplicor ct/ng for ct method manual, verification of ct antigen or nucleic acid with an alternate method is recommended by the cdc. Although requested, no patient samples were provided by the customer for further investigative testing. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[14965654] A customer site in (b)(6) has alleged that they had two samples that generated (b)(6) results however when redetected generated (b)(6) results (being reported through mdr 2243471-2011-00083 and -00084) with the cobas amplicor chlamydia trachomatis test. Specifically, the customer indicated that they had two recent runs within a two week time frame where a sample that was (b)(6) was redetected and generated (b)(6) results with the cobas amplicor chlamydia trachomatis test. The customer indicated that the samples were redetected due to a hardware error that occurred mid-run. Note: re-amplification and re-detection of a sample with the cobas amplicor chlamydia trachomatis test is off-label practice.
Patient Sequence No: 1, Text Type: D, B5


[15168391] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of this investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2011-00084
MDR Report Key2249010
Report Source05
Date Received2011-09-15
Date of Report2011-08-17
Date of Event2011-08-16
Date Mfgr Received2011-09-26
Date Added to Maude2012-02-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLICOR CHLAMYDIA TACHOMATIS TEST
Generic NameDNA PROBE, NUCLEIC ACID AMPLIFICATION, CHLAMYDIA
Product CodeMKZ
Date Received2011-09-15
Catalog Number20757497122
OperatorMEDICAL TECHNOLOGIST
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2011-09-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.